Use and continuity of weight-modifying medications among adults with diabetes and overweight/obesity: US population study.

Rodolfo J GalindoTegveer S UppalRozalina Grubina McCoy Guillermo E Umpierrez Mohammed K Ali

Published in: Obesity (Silver Spring, Md.) (2023)

Over 2010-2019, 64.9% of adults with diabetes and overweight/obesity were treated with WI medications, 13.5% with WR medications, and 73.1% with WN medications. Discontinuation of WR medications was nearly twice that of WI medications.

Keyphrases

weight loss
type diabetes
weight gain
cardiovascular disease
physical activity
metabolic syndrome
insulin resistance
glycemic control
body mass index
adipose tissue